F Acadia Pharmaceuticals Inc Transaction History
F
- $2.07 Billion
- Q1 2025
A detailed history of F transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, F holds 68,753 shares of ACAD stock, worth $1.51 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
68,753
Previous 64,660
6.33%
Holding current value
$1.51 Million
Previous $1.19 Million
3.79%
% of portfolio
0.06%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$944 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$335 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$266 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$188 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$154 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.56B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...